Literature DB >> 19800377

Biodegradation, biodistribution and toxicity of chitosan.

T Kean1, M Thanou.   

Abstract

Chitosan is a natural polysaccharide that has attracted significant scientific interest during the last two decades. It is a potentially biologically compatible material that is chemically versatile (-NH2 groups and various M(w)). These two basic properties have been used by drug delivery and tissue engineering scientists to create a plethora of formulations and scaffolds that show promise in healthcare. Despite the high number of published studies, chitosan is not approved by the FDA for any product in drug delivery, and as a consequence very few biotech companies are using this material. This review will aim to provide information on these biological properties that affect chitosan's safe use in drug delivery. The term "Chitosan" represents a large group of structurally different chemical entities that may show different biodistribution, biodegradation and toxicological profiles. Here we aim to review research in this area and critically discuss chitosan's potential to be used as a generally regarded as safe (GRAS) material. 2009 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19800377     DOI: 10.1016/j.addr.2009.09.004

Source DB:  PubMed          Journal:  Adv Drug Deliv Rev        ISSN: 0169-409X            Impact factor:   15.470


  215 in total

Review 1.  Recent advancement of chitosan-based nanoparticles for oral controlled delivery of insulin and other therapeutic agents.

Authors:  Anumita Chaudhury; Surajit Das
Journal:  AAPS PharmSciTech       Date:  2010-12-11       Impact factor: 3.246

2.  Biopolymer based nanosystem for doxorubicin targeted delivery.

Authors:  Zsuzsanna Csikós; Krisztina Kerekes; Erika Fazekas; Sándor Kun; János Borbély
Journal:  Am J Cancer Res       Date:  2017-03-01       Impact factor: 6.166

Review 3.  Chitosan: a promising safe and immune-enhancing adjuvant for intranasal vaccines.

Authors:  Alan Smith; Michael Perelman; Michael Hinchcliffe
Journal:  Hum Vaccin Immunother       Date:  2013-12-17       Impact factor: 3.452

4.  In vitro treatments of Echinococcus granulosus with fungal chitosan, as a novel biomolecule.

Authors:  Bahman Rahimi-Esboei; Mahdi Fakhar; Aroona Chabra; Mahboobeh Hosseini
Journal:  Asian Pac J Trop Biomed       Date:  2013-09-04

5.  Effects of molecular weights on the absorption, distribution and urinary excretion of intraperitoneally administrated carboxymethyl chitosan in rats.

Authors:  Wen Dong; Baoqin Han; Kai Shao; Zhao Yang; Yanfei Peng; Yan Yang; Wanshun Liu
Journal:  J Mater Sci Mater Med       Date:  2012-08-14       Impact factor: 3.896

6.  Systemically administered brain-targeted nanoparticles transport peptides across the blood-brain barrier and provide neuroprotection.

Authors:  Muge Yemisci; Secil Caban; Yasemin Gursoy-Ozdemir; Sevda Lule; Ramon Novoa-Carballal; Ricardo Riguera; Eduardo Fernandez-Megia; Karine Andrieux; Partick Couvreur; Yilmaz Capan; Turgay Dalkara
Journal:  J Cereb Blood Flow Metab       Date:  2014-12-10       Impact factor: 6.200

7.  Overcoming cisplatin resistance in non-small cell lung cancer with Mad2 silencing siRNA delivered systemically using EGFR-targeted chitosan nanoparticles.

Authors:  Ana Vanessa Nascimento; Amit Singh; Hassan Bousbaa; Domingos Ferreira; Bruno Sarmento; Mansoor M Amiji
Journal:  Acta Biomater       Date:  2016-09-30       Impact factor: 8.947

8.  Rational design of multistage drug delivery vehicles for pulmonary RNA interference therapy.

Authors:  A Sofia Silva; Kevin E Shopsowitz; Santiago Correa; Stephen W Morton; Erik C Dreaden; Teresa Casimiro; Ana Aguiar-Ricardo; Paula T Hammond
Journal:  Int J Pharm       Date:  2020-10-26       Impact factor: 5.875

9.  Dual Functional Lysozyme-Chitosan Conjugate for Tunable Degradation and Antibacterial Activity.

Authors:  Soyon Kim; Jiabing Fan; Chung-Sung Lee; Min Lee
Journal:  ACS Appl Bio Mater       Date:  2020-03-08

10.  Chitosan-zinc-insulin complex incorporated thermosensitive polymer for controlled delivery of basal insulin in vivo.

Authors:  Mayura Oak; Jagdish Singh
Journal:  J Control Release       Date:  2012-08-07       Impact factor: 9.776

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.